Esperion Therapeutics
ESPR
#6169
Rank
ยฃ0.66 B
Marketcap
ยฃ2.80
Share price
-1.58%
Change (1 day)
6.96%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -ยฃ21.43 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are ยฃ0.30 Billion. In 2024 the company made an earning of ยฃ5.63 Million, an increase over its 2023 earnings that were of -ยฃ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ21.43 Million-480.25%
2024 ยฃ5.63 M-104.99%
2023 -ยฃ0.12 Billion-15.03%
2022 -ยฃ0.14 Billion-20.61%
2021 -ยฃ0.17 Billion84.28%
2020 -ยฃ90.74 Million35.75%
2019 -ยฃ66.85 Million-55.71%
2018 -ยฃ0.16 Billion19.57%
2017 -ยฃ0.13 Billion125.39%
2016 -ยฃ56 Million51.43%
2015 -ยฃ36.99 Million36.45%
2014 -ยฃ27.11 Million43.55%
2013 -ยฃ18.88 Million145.26%
2012 -ยฃ7.7 Million
2002 -ยฃ21.95 Million-7.81%
2001 -ยฃ23.81 Million15.03%
2000 -ยฃ20.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-ยฃ0.39 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.50 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.89 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.86 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ3.73 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ51.48 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA